Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Denosumab on Bone Mineral Density, Markers of Bone Metabolism and Bone Microarchitecture in Women With Anorexia Nervosa: A Pilot Study

NCT03292146 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT03292146
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03292146 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Denosumab on Bone Mineral Density, Markers of Bone Metabolism and Bone Microarchitecture in Women With Anorexia Nervosa: A Pilot Study
Lead sponsor
Massachusetts General Hospital
Phase
Phase 3
Overall status
Completed
Start date
October 25, 2017
Completion date
July 22, 2021
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anorexia nervosa, atypical anorexia nervosa, bone density, bone loss, eating disorder